Daily Briefing

5 minute read

What the 2026 midterm results mean for healthcare


Democrats took control of both the House and Senate in the 2026 midterm elections, setting the stage for a significant shift in healthcare policymaking over the next two years. In a recent Radio Advisory episode, host Abby Burns spoke with Advisory Board experts Natalie Trebes and Ben Palmer to discuss what the midterm results mean for healthcare.

Below is an overview of key takeaways from the interview. Download the episode to hear the full conversation.

A consequential election, but not necessarily a transformational one

The most important thing for healthcare leaders to understand is that Democrats' victory in Congress doesn't fundamentally erase the healthcare policies enacted under President Donald Trump, Palmer noted.

"I would say the sort of take-home point for me has been it is consequential, but it's not necessarily transformational," he said.

While Democrats will control both chambers of Congress, they don't have a veto-proof majority in the Senate. That means they can pass legislation advancing their priorities, but President Donald Trump can ultimately veto those bills.

Trebes suggested thinking about the results as "consequential to set up for potential transformation." Democrats now have an opportunity to lay the groundwork for where healthcare policy could go in future years, including ahead of the 2028 presidential election.

Palmer said he expects that could include "message bills" designed to signal Democrats' priorities even if they aren't ultimately enacted. For example, Congress could potentially explore what broader Medicare expansion would look like, even while knowing that such legislation faces a presidential veto.

"They're going to pass agenda bills that they're going to force Trump to veto," Palmer said. "And that I think is going to set up the 2028 conversation."

Watch must-pass legislation and bipartisan issues

Message bills aren't the only legislative path available to Democrats. Palmer said healthcare leaders should pay attention to must-pass legislation, where Democrats may have more leverage to negotiate policy changes.

Government funding will be one early test, as a future budget fight could give Democrats an opportunity to push for policies such as restoring enhanced Affordable Care Act subsidies or delaying Medicaid work requirements.

Another opportunity comes with FDA user fee reauthorization, which Palmer noted has previously been used to advance other FDA-related policies. Democrats could try to attach additional priorities to that legislation while also using their congressional majorities to increase oversight of HHS and FDA.

Meanwhile, a divided government doesn't necessarily mean bipartisan healthcare legislation is off the table.

Palmer pointed to the No Surprises Act as well as pharmacy benefit managers as areas where members of both parties have previously shown interest in reform. Trebes highlighted additional areas where Republicans and Democrats at least share a recognition that problems exist, including AI, interoperability, prior authorization, and Medicare Advantage.

However, agreement that a problem exists doesn't necessarily mean lawmakers agree on the solution.

"I think there are a lot of areas that have shared acknowledgement of some sort of problem, of some sort of need for action," Trebes said. From there, she added, lawmakers can differ over which stakeholders to prioritize and what ideological approach the government should take.

Another question is how much Congress can accomplish. Many lawmakers will be new, requiring healthcare organizations to build relationships and educate them about the complexities of healthcare delivery and financing, Trebes said. Democrats will also devote resources to oversight of the Trump administration and the implementation of existing laws.

For healthcare leaders, Palmer said that makes it especially important not to equate political attention with operational significance.

"I think it's important to not confuse high political salience with high operational relevance for healthcare leaders," he said. "There may be some really loud debates about things that have less of an immediate impact than a payment rule or some kind of state Medicaid decision, or some of these, quote, unquote, 'smaller things' that happen."

The One Big Beautiful Bill Act isn't going away

The election also raises questions about the future of the One Big Beautiful Bill Act (OBBBA), particularly as major Medicaid provisions begin taking effect. The key message for healthcare leaders: The law remains in place.

Trebes noted, however, that the election could still affect OBBBA's implementation because several state governments changed partisan control. That's significant because much of the law requires action at the state level, where officials have decisions to make about different factors including eligibility, enrollment, and how to respond to budget pressures.

Congress may also seek changes to the law, but healthcare organizations shouldn't assume Democratic control means its major provisions will disappear.

"Maybe on the margins, there are some avenues in which changes to [OBBBA] could happen or implementation of [OBBBA]," Palmer said. "But I mean, I think the first thing to remember is that it is still law."

For example, Palmer said must-pass legislation could potentially provide opportunities to delay or modify implementation of Medicaid provisions even if outright repeal isn't achievable.

What should healthcare leaders do now?

For healthcare organizations trying to make sense of a rapidly evolving political environment, Palmer's first recommendation is to distinguish between actual policy change and political noise.

"Ask whether something actually became law or just became more politically likely or simply just became louder after the election happened," he said.

Leaders should also closely monitor developments in their own states, particularly because state governments will play a significant role in OBBBA implementation. And despite the possibility of future modifications or delays, organizations should continue preparing for Medicaid changes and other provisions already written into law.

Trebes added another priority: Healthcare organizations need to get better at demonstrating the impact of policy decisions.

That means collecting evidence not only about how federal and state policies affect an organization's business, but also about what happens when organizations intervene. If an organization dedicates case managers to Medicaid eligibility redeterminations, for example, leaders should be prepared to demonstrate what difference those investments made for patients, the business, and the community.

That evidence could grow more valuable ahead of the 2028 election, when Palmer expects healthcare to become more politically salient as voters experience the effects of policies being implemented today.

"I think by 2028, voters won't just be debating what these policies might do in the future," he said. "There's going to be evidence about what they have already done, and I think that's going to be top of mind."

For Trebes, one of the biggest immediate questions is how Democrats use their new oversight authority, including whether hearings and investigations primarily produce political theater or are strategically connected to policy changes Democrats hope to achieve.

The election settled who will control Congress for the next two years. But the consequences for healthcare will depend on what lawmakers do with that power, how existing policies are implemented, and how effectively healthcare organizations can demonstrate their effects.

Hands-on support to help deliver the results you need

Optum consulting has a team of thousands of industry professionals with expertise earned from years in our fields. We’re here to work side-by-side with you to build organizations that last. 


SPONSORED BY

INTENDED AUDIENCE

AFTER YOU READ THIS

AUTHORS

TOPICS

INDUSTRY SECTORS

RELATED RESOURCES

Don't miss out on the latest Advisory Board insights

Create your free account to access 1 resource, including the latest research and webinars.

Want access without creating an account?

   

You have 1 free members-only resource remaining this month.

1 free members-only resources remaining

1 free members-only resources remaining

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox

This content is available through your Curated Research partnership with Advisory Board. Click on ‘view this resource’ to read the full piece

Email ask@advisory.com to learn more

Click on ‘Become a Member’ to learn about the benefits of a Full-Access partnership with Advisory Board

Never miss out on the latest innovative health care content tailored to you. 

Benefits Include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox

This is for members only. Learn more.

Click on ‘Become a Member’ to learn about the benefits of a Full-Access partnership with Advisory Board

Never miss out on the latest innovative health care content tailored to you. 

Benefits Include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox
AB
Thank you! Your updates have been made successfully.
Oh no! There was a problem with your request.
Error in form submission. Please try again.